However, induction of BIM by MEK or KRASG12C inhibition alone is often insufficient to induce apoptosis in KRAS-mutant cancer cells because BIM is bound and neutralized by pro-survival BCL-2 family proteins such as BCLX-XL or MCL-1. This evidence concerns the gene MAP2K7 and cancer.